In the rapidly evolving biopharmaceutical landscape, biologics or ‘large molecule’ therapies have emerged as a crucial segment, promising innovative treatments for a wide-range of diseases. 90% of biotechs choose to partner with a Contract Development and Manufacturing Organisation (CDMO) to
Skyepharma is a fully-integrated CDMO specialised in formulating, developing and producing complex oral dosage forms and expanding into Bioproduction with the opening of their new SkyeHub plant. Based outside Lyon, France, the company offers their worldwide customer base a full
Stay ahead of trends and best practices
Exclusive downloads and podcasts
Get invites to special events and meetups 
Help us find the most innovative and trusted suppliers in Pharma and Biotech.
